Tracking TBI: neuromonitoring for brain injuries
UC expert discusses advances in neurocritical care with Albany, Georgia's WALB
The University of Cincinnati's Brandon Foreman, MD, discussed advances in multimodal neuromonitoring with Albany, Georgia's WALB-TV.
Like traditional monitoring of a patient's heart rate, blood pressure and oxygen levels, multimodal neuromonitoring tracks similar brain health data points for patients with traumatic brain injuries. Measurements like blood flow, pressure, oxygen and glucose levels in the brain give actionable information over time when treating patients with severe brain trauma.
"What’s happening in the patient on day one is often very different compared to what’s happening to that patient on day three," said Foreman, associate professor of neurology and associate director of neurocritical care research in the Department of Neurology and Rehabilitation Medicine in UC’s College of Medicine and a UC Gardner Neuroscience Institute physician. "We’re learning a lot about what those patterns look like, how individual they are and how we can treat them in a more precise way tailored to that patient."
Read more about multimodal neuromonitoring work at UC.
Featured photo at top of Foreman reviewing brain data on a monitor. Photo/Andrew Higley/UC Marketing + Brand.
Related Stories
CCM welcomes new film and media scoring faculty member J.R. Paredes
May 20, 2026
UC College-Conservatory of Music Dean Pete Jutras has announced the appointment of J.R. Paredes as CCM's new Assistant Professor of Film and Media Scoring. His faculty appointment officially begins on Aug. 15, 2026. Paredes is a composer, music producer and audio post-production specialist whose work spans film, television and commercial music. His credits include original scores for feature films and series distributed on platforms such as Apple TV+ and Prime Video, as well as extensive work in sound design and mixing for film and media.
6 ways starting a GLP-1 medication could affect your emotions
May 20, 2026
When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.